170 related articles for article (PubMed ID: 30187871)
1. [
An H; Lin J; Sun H; Xu L; Su J; He C; Zeng J; Liang P; He S
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jul; 38(8):997-1001. PubMed ID: 30187871
[TBL] [Abstract][Full Text] [Related]
2. ROCK is involved in vasculogenic mimicry formation in hepatocellular carcinoma cell line.
Zhang JG; Li XY; Wang YZ; Zhang QD; Gu SY; Wu X; Zhu GH; Li Q; Liu GL
PLoS One; 2014; 9(9):e107661. PubMed ID: 25238232
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling.
Zhang JG; Zhou HM; Zhang X; Mu W; Hu JN; Liu GL; Li Q
BMC Cancer; 2020 Jan; 20(1):32. PubMed ID: 31931758
[TBL] [Abstract][Full Text] [Related]
4. [Effect of Biejiajian Pills on Wnt/β-catenin signal pathway and DKK-1 and FrpHe gene expressions in hepatocellular carcinoma cells].
He S; Cheng Y; Zhu Y; Fan Q; Sun H; Jia W
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):30-3. PubMed ID: 23353151
[TBL] [Abstract][Full Text] [Related]
5. [Effect of Biejiajian Pills on Wnt signal pathway molecules β-catenin and GSK-3β and the target genes CD44v6 and VEGF in hepatocellular carcinoma cells].
Sun H; He S; Wen B; Jia W; Fan E; Zheng Y
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Oct; 34(10):1454-8. PubMed ID: 25345941
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect of Biejiajian pills on HepG2 cell xenograft growth and expression of β-catenin and Tbx3 in nude mice].
Wen B; Sun HT; He SQ; LA L; An HY; Pang J
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 36(2):210-4. PubMed ID: 26922018
[TBL] [Abstract][Full Text] [Related]
7. Baicalein suppresses vasculogenic mimicry through inhibiting RhoA/ROCK expression in lung cancer A549 cell line.
Zhang Z; Nong L; Chen M; Gu X; Zhao W; Liu M; Cheng W
Acta Biochim Biophys Sin (Shanghai); 2020 Sep; 52(9):1007-1015. PubMed ID: 32672788
[TBL] [Abstract][Full Text] [Related]
8. Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1-mediated EMT.
Zhang N; Zhang S; Wu W; Lu W; Jiang M; Zheng N; Huang J; Wang L; Liu H; Zheng M; Wang J
Mol Carcinog; 2021 Feb; 60(2):151-163. PubMed ID: 33428809
[TBL] [Abstract][Full Text] [Related]
9. [Effects of Biejiajian Pills on Wnt signal pathway signal molecules β-catenin/TCF4 complex activities and downstream proteins cyclin D1 and MMP-2 in hepatocellular carcinoma cells].
Wen B; Sun H; He S; Cheng Y; Jia W; Fan E; Pang J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1758-62. PubMed ID: 25537897
[TBL] [Abstract][Full Text] [Related]
10. RhoC/ROCK2 promotes vasculogenic mimicry formation primarily through ERK/MMPs in hepatocellular carcinoma.
Zhang JG; Zhang DD; Liu Y; Hu JN; Zhang X; Li L; Mu W; Zhu GH; Li Q; Liu GL
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1113-1125. PubMed ID: 30779947
[TBL] [Abstract][Full Text] [Related]
11. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
[TBL] [Abstract][Full Text] [Related]
12. Incarvine C suppresses proliferation and vasculogenic mimicry of hepatocellular carcinoma cells via targeting ROCK inhibition.
Zhang JG; Zhang DD; Wu X; Wang YZ; Gu SY; Zhu GH; Li XY; Li Q; Liu GL
BMC Cancer; 2015 Oct; 15():814. PubMed ID: 26510899
[TBL] [Abstract][Full Text] [Related]
13. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
Xia Y; Cai X; Fan J; Zhang L; Li Z; Ren J; Wu G; Zhu F
Anticancer Drugs; 2017 Jun; 28(5):514-521. PubMed ID: 28225457
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor suppresses vasculogenic mimicry in hepatocellular carcinoma via circRNA7/miRNA7-5p/VE-cadherin/Notch4 signalling.
Bao S; Jin S; Wang C; Tu P; Hu K; Lu J
J Cell Mol Med; 2020 Dec; 24(23):14110-14120. PubMed ID: 33118329
[TBL] [Abstract][Full Text] [Related]
15. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry.
Sun T; Zhao N; Zhao XL; Gu Q; Zhang SW; Che N; Wang XH; Du J; Liu YX; Sun BC
Hepatology; 2010 Feb; 51(2):545-56. PubMed ID: 19957372
[TBL] [Abstract][Full Text] [Related]
16. Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling.
Jue C; Lin C; Zhisheng Z; Yayun Q; Feng J; Min Z; Haibo W; Youyang S; Hisamitsu T; Shintaro I; Shiyu G; Yanqing L
Oncotarget; 2017 Jan; 8(2):2501-2513. PubMed ID: 27705934
[TBL] [Abstract][Full Text] [Related]
17. The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms.
Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Li ZY; Zhang RG; Zhu F; Wu G
Int J Cancer; 2019 May; 144(9):2227-2238. PubMed ID: 30374974
[TBL] [Abstract][Full Text] [Related]
18. Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma.
Yang J; Lu Y; Lin YY; Zheng ZY; Fang JH; He S; Zhuang SM
Cancer Lett; 2016 Dec; 383(1):18-27. PubMed ID: 27693460
[TBL] [Abstract][Full Text] [Related]
19. Polyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathway.
Xiao T; Zhong W; Zhao J; Qian B; Liu H; Chen S; Qiao K; Lei Y; Zong S; Wang H; Liang Y; Zhang H; Meng J; Zhou H; Sun T; Liu Y; Yang C
Cell Death Dis; 2018 Sep; 9(9):906. PubMed ID: 30185783
[TBL] [Abstract][Full Text] [Related]
20. [Three-dimensional cell culture and histology of vasculogenic mimicry in hepatocellular carcinoma].
Zhao J; Huang JS; Yang AJ; Wang CY; Liu W; Li M
Ai Zheng; 2007 Feb; 26(2):123-6. PubMed ID: 17298738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
